← Every company
Amylyx Pharmaceuticals Inc Planned Sales
Before an insider at Amylyx Pharmaceuticals Inc can sell restricted stock they have to file notice of it. This is that notice — the leading edge of the insider trading feed, filed days before the sale it describes.
AMLX insider trades →Notices on file
6
Insiders
6
Shares noticed
191.3K
permission to sell, not sales
Estimated value
$5.7M
as estimated on filing
Largest notices first
Value is the filer's own estimate of what the sale would raise, at the time they filed.
| Seller | Est. value |
|---|---|
| Milne GeorgeDirector2026-10-05100K sh0.09% | $2.8M |
| Joshua B CohenOfficer, Director2026-09-1030.5K sh0.84% | $980.5K |
| Justin B. KleeOfficer, Director2026-09-1030.5K sh0.84% | $980.3K |
| James M FratesOfficer2026-09-1010.8K sh4.63% | $349.8K |
| Camille L BedrosianOfficer2026-09-1010K sh3.61% | $324.9K |
| Gina MazzarielloOfficer2026-09-109.5K sh5.00% | $309.5K |
Source: SEC Form 144 notices, via EDGAR. A notice is permission to sell, not a completed sale — it is often used only in part, or not at all, so none of this is volume and none of it should be added to the insider trading feed. Value is the filer's estimate on the day they filed.
More on AMLX
Company overviewEverything on AMLX in one place, with the price.SEC filingsWhat AMLX's 8-Ks say happened: results, departures, auditor changes.Insider tradingWhat AMLX's own officers and directors buy and sell.Who owns itEvery manager reporting a position in AMLX.Funds holding itWhich funds and ETFs hold AMLX, and how big a bet.LobbyingWhat AMLX spends lobbying Congress, and on what.Who lobbies for itThe lobbyists on AMLX's account, and who they worked for.PatentsWhat AMLX is filing at the patent office.